Novel time-dependent vascular actions of Δ9- tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma

Biochemical and Biophysical Research Communications

Volumn 337, Issue 3, 2005, Pages 824-831

  O'Sullivan, Saoirse E ^a   Tarling, Elizabeth J ^a   Bennett, Andrew J ^a   Kendall, David A ^a   Randall, Michael D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aorta; Cannabinoid; Endothelium; Nitric oxide; PPAR ; SOD; Superior mesenteric artery; THC; Vasorelaxation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; HYDROGEN PEROXIDE; LUCIFERASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; ROSIGLITAZONE;

ADIPOCYTE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CELL STRAIN HEK293; HUMAN; HUMAN CELL; INCUBATION TIME; ISOLATED ARTERY; MALE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REPORTER GENE; TRANSACTIVATION; VASODILATATION;

ANIMALS; AORTA; KINETICS; MALE; MESENTERIC ARTERY, SUPERIOR; PPAR GAMMA; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TETRAHYDROCANNABINOL; TIME FACTORS; TRANS-ACTIVATION (GENETICS); VASODILATION;

CANNABIS;

EID: 26844551263     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.121     Document Type: Article

References (30)

1. P. Ferre The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 53 2004 S43 S50
2. D. Bishop-Bailey Peroxisome proliferator-activated receptors in the cardiovascular system Br. J. Pharmacol. 129 2000 823 834
3. J. Fu, S. Gaetani, F. Oveisi, J. Lo Verme, A. Serrano, F. Rodriguez De Fonseca, A. Rosengarth, H. Luecke, B. Di Giacomo, G. Tarzia, and D. Piomelli Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha Nature 425 2003 90 93
4. K.R. Kozak, B.C. Crews, J.D. Morrow, L.H. Wang, Y.H. Ma, R. Weinander, P.J. Jakobsson, and L.J. Marnett 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist J. Biol. Chem. 277 2002 23278 23286
5. J. Liu, H. Li, S.H. Burstein, R.B. Zurier, and J.D. Chen Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid Mol. Pharmacol. 63 2003 983 992
6. J. Lo Verme, J. Fu, G. Astarita, G. La Rana, R. Russo, A. Calignano, and D. Piomelli The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide Mol. Pharmacol. 67 2005 15 19
7. O. Braissant, F. Foufelle, C. Scotto, M.M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 1996 354 366
8. S.M. Rangwala, and M.A. Lazar Peroxisome proliferator-activated receptor gamma in diabetes and metabolism Trends Pharmacol. Sci. 25 2004 331 336
9. W.A. Hsueh, and D. Bruemmer Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease Hypertension 43 2004 297 305
10. 9-tetrahydrocannabinol (THC) and its interactions with the endocannabinoid anandamide Br. J. Pharmacol. 145 2005 514 526
11. 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta Eur. J. Pharmacol. 507 2005 211 221
12. S.E. Cunnane, Y.Y. Chan, M.D. Randall, Rosiglitazone-induced vasorelaxation in the rat aorta, Proc. Br. Pharm. Soc. (2004). 〈 http://www.pa2online.org//〉 Vol2Issue2abst096P.
13. M.J. Mulvany, and W. Halpern Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ. Res. 41 1977 19 26
14. L.M. Leesnitzer, D.J. Parks, R.K. Bledsoe, J.E. Cobb, J.L. Collins, T.G. Consler, R.G. Davis, E.A. Hull-Ryde, J.M. Lenhard, L. Patel, K.D. Plunket, J.L. Shenk, J.B. Stimmel, C. Therapontos, T.M. Willson, and S.G. Blanchard Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662 Biochemistry 41 2002 6640 6650
15. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors Eur. J. Pharmacol. 307 1996 331 338
16. R. White, and C.R. Hiley Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation Eur. J. Pharmacol. 339 1997 157 160
17. A. MacKenzie, and W. Martin Loss of endothelium-derived nitric oxide in rabbit aorta by oxidant stress: restoration by superoxide dismutase mimetics Br. J. Pharmacol. 124 1998 719 728
18. E. Mueller, S. Drori, A. Aiyer, J. Yie, P. Sarraf, H. Chen, S. Hauser, E.D. Rosen, K. Ge, R.G. Roeder, and B.M. Spiegelman Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms J. Biol. Chem. 277 2002 41925 41930
19. Z. Bagi, A. Koller, and G. Kaley PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes Am. J. Physiol. 286 2004 H742 H748
20. D.H. Cho, Y.J. Choi, S.A. Jo, and I. Jo Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signalling pathways J. Biol. Chem. 279 2004 2499 2506
21. H.Y. Ling, S.D. Feng, S.H. Zhou, B.X. Wang, X.Q. Liu, and B. Hu Effects of rosiglitazone on aortic function in rats with insulin resistant-hypertension Sheng Li Xue Bao 57 2005 125 131
22. J.B. Majithiya, A.N. Paramar, and R. Balaraman Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats Cardiovasc. Res. 66 2005 150 161
23. S. Fujimoto, T. Asano, M. Sakai, K. Sakurai, D. Takagi, N. Yoshimoto, and T. Itoh Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery Eur. J. Pharmacol. 412 2001 291 300
24. A. Sato, I. Sakuma, and D.D. Gutterman Mechanism of dilation to reactive oxygen species in human coronary arterioles Am. J. Physiol. Heart Circ. Physiol. 285 2003 H2345 H2354
25. J. Hwang, D.J. Kleinhenz, B. Lassegue, K.K. Griendling, S. Dikalov, and C.M. Hart Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production Am. J. Physiol. Cell Physiol. 288 2005 C899 C905
26. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
27. H. Tsukamoto, T. Hishinuma, N. Suzuki, R. Tayama, M. Hiratsuka, T. Yoshihisa, M. Mizugaki, and J. Goto Thiazolidinediones increase arachidonic acid release and subsequent prostanoid production in a peroxisome proliferator-activated receptor gamma-independent manner Prostaglandins Other Lipid Mediat. 73 2004 191 213
28. S. Steffens, N.R. Veillard, C. Arnaud, G. Pelli, F. Burger, C. Staub, A. Zimmer, J.L. Frossard, and F. Mach Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice Nature 434 2005 782 786
29. M.A. Rumi, S. Ishihara, H. Kazumori, Y. Kadowaki, and Y. Kinoshita Can PPAR gamma ligands be used in cancer therapy? Curr. Med. Chem. Anti-Cancer Agents 4 2004 465 477
30. C. Alarcon de la Lastra, S. Sanchez-Fidalgo, I. Villegas, and V. Motilva New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists Curr. Pharm. Des. 10 2004 3505 3524